1
|
Molina R, Redondo P, Stella S, Marenchino M, D’Abramo M, Gervasio FL, Charles Epinat J, Valton J, Grizot S, Duchateau P, Prieto J, Montoya G. Non-specific protein-DNA interactions control I-CreI target binding and cleavage. Nucleic Acids Res 2012; 40:6936-45. [PMID: 22495931 PMCID: PMC3413129 DOI: 10.1093/nar/gks320] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Homing endonucleases represent protein scaffolds that provide powerful tools for genome manipulation, as these enzymes possess a very low frequency of DNA cleavage in eukaryotic genomes due to their high specificity. The basis of protein–DNA recognition must be understood to generate tailored enzymes that target the DNA at sites of interest. Protein–DNA interaction engineering of homing endonucleases has demonstrated the potential of these approaches to create new specific instruments to target genes for inactivation or repair. Protein–DNA interface studies have been focused mostly on specific contacts between amino acid side chains and bases to redesign the binding interface. However, it has been shown that 4 bp in the central DNA sequence of the 22-bp substrate of a homing endonuclease (I-CreI), which do not show specific protein–DNA interactions, is not devoid of content information. Here, we analyze the mechanism of target discrimination in this substrate region by the I-CreI protein, determining how it can occur independently of the specific protein–DNA interactions. Our data suggest the important role of indirect readout in this substrate region, opening the possibility for a fully rational search of new target sequences, thus improving the development of redesigned enzymes for therapeutic and biotechnological applications.
Collapse
Affiliation(s)
- Rafael Molina
- Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Macromolecular Crystallography Group, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Computational Biophysics Group, c/Melchor Fdez. Almagro 3, 28029 Madrid, Spain and CELLECTIS S.A., 8 rue de la croix Jarry, 75013 Paris, France
| | - Pilar Redondo
- Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Macromolecular Crystallography Group, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Computational Biophysics Group, c/Melchor Fdez. Almagro 3, 28029 Madrid, Spain and CELLECTIS S.A., 8 rue de la croix Jarry, 75013 Paris, France
| | - Stefano Stella
- Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Macromolecular Crystallography Group, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Computational Biophysics Group, c/Melchor Fdez. Almagro 3, 28029 Madrid, Spain and CELLECTIS S.A., 8 rue de la croix Jarry, 75013 Paris, France
| | - Marco Marenchino
- Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Macromolecular Crystallography Group, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Computational Biophysics Group, c/Melchor Fdez. Almagro 3, 28029 Madrid, Spain and CELLECTIS S.A., 8 rue de la croix Jarry, 75013 Paris, France
| | - Marco D’Abramo
- Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Macromolecular Crystallography Group, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Computational Biophysics Group, c/Melchor Fdez. Almagro 3, 28029 Madrid, Spain and CELLECTIS S.A., 8 rue de la croix Jarry, 75013 Paris, France
| | - Francesco Luigi Gervasio
- Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Macromolecular Crystallography Group, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Computational Biophysics Group, c/Melchor Fdez. Almagro 3, 28029 Madrid, Spain and CELLECTIS S.A., 8 rue de la croix Jarry, 75013 Paris, France
| | - Jean Charles Epinat
- Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Macromolecular Crystallography Group, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Computational Biophysics Group, c/Melchor Fdez. Almagro 3, 28029 Madrid, Spain and CELLECTIS S.A., 8 rue de la croix Jarry, 75013 Paris, France
| | - Julien Valton
- Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Macromolecular Crystallography Group, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Computational Biophysics Group, c/Melchor Fdez. Almagro 3, 28029 Madrid, Spain and CELLECTIS S.A., 8 rue de la croix Jarry, 75013 Paris, France
| | - Silvestre Grizot
- Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Macromolecular Crystallography Group, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Computational Biophysics Group, c/Melchor Fdez. Almagro 3, 28029 Madrid, Spain and CELLECTIS S.A., 8 rue de la croix Jarry, 75013 Paris, France
| | - Phillipe Duchateau
- Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Macromolecular Crystallography Group, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Computational Biophysics Group, c/Melchor Fdez. Almagro 3, 28029 Madrid, Spain and CELLECTIS S.A., 8 rue de la croix Jarry, 75013 Paris, France
| | - Jesús Prieto
- Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Macromolecular Crystallography Group, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Computational Biophysics Group, c/Melchor Fdez. Almagro 3, 28029 Madrid, Spain and CELLECTIS S.A., 8 rue de la croix Jarry, 75013 Paris, France
- *To whom correspondence should be addressed. Tel: +34 91 2246900; Fax: +34 91 2246976;
| | - Guillermo Montoya
- Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Macromolecular Crystallography Group, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Computational Biophysics Group, c/Melchor Fdez. Almagro 3, 28029 Madrid, Spain and CELLECTIS S.A., 8 rue de la croix Jarry, 75013 Paris, France
- *To whom correspondence should be addressed. Tel: +34 91 2246900; Fax: +34 91 2246976;
| |
Collapse
|